Electrochemotherapy of Gynecological Cancers

  • End date
    Dec 31, 2025
  • participants needed
  • sponsor
    Institute of Oncology Ljubljana
Updated on 26 February 2021


To determine the effectiveness, feasibility and safety of electrochemotherapy in treatment of local and/or regional recurrences of gynecological cancers with electrochemotherapy in which standard treatment options have been exhausted.

Condition Uterine Cancer, Brenner Tumor, UTERINE FIBROID, Uterine Fibroids, Leiomyomas
Treatment Electrochemotherapy with bleomycin or cisplatin
Clinical Study IdentifierNCT04760327
SponsorInstitute of Oncology Ljubljana
Last Modified on26 February 2021


Yes No Not Sure

Inclusion Criteria

Local or regional relapse of gynecological tumors in which standard treatment options have been exhausted
Age more than 18
Life expectancy more than 3 month
Performance status Karnofsky 70 or WHO < or 2
Treatment free interval minimum 2 weeks
Patient must be mentally capable of understanding the given information and regarding treatment and any adverse reactions that may occur during treatment
Patient must give informed consent
Patient must be discussed at the multidisciplinary team before entering the trial
Patient should be suitable for anesthesia

Exclusion Criteria

Visceral, bone or diffuse metastases
Life-threatening infection and/or heart failure and/or liver failure and/or other severe systemic pathologies
Significant reduction in respiratory function
Age less than 18 years
Coagulation disturbances (those who do not respond on standard treatment with vitamin-K or fresh frozen plasma)
Cumulative dose of 400 mg/m2 bleomycin received
Impaired kidney function (creatinin > 150 mol/l)
Patients with epilepsy
Patient incapable of understanding the aim of the study or disagree with the entering into the clinical study
Clear my responses

How to participate?

Step 1 Connect with a site
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact


Preferred Language
Other Language
Please verify that you are not a bot.

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider


Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 



Reply by • Private

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note